Results 181 to 190 of about 29,580 (292)
Pharmacokinetic Monitoring of JAK Inhibitor and Tacrolimus for Safe and Effective Management of Graft-Versus-Host Disease After Pediatric Liver Transplantation. [PDF]
Pediatr TransplantSawada K +5 more
europepmc +1 more source
Pilot Study of Tildrakizumab in the Treatment of Stable Non‐Segmental Vitiligo
JEADV Clinical Practice, Volume 4, Issue 5, Page 1140-1145, December 2025.ABSTRACT Background Treatment for vitiligo is limited, with variable efficacy, and can be time‐consuming or expensive. Recent developments within biologic therapy have demonstrated promising results with managing chronic autoimmune conditions. Objectives To evaluate the efficacy of tildrakizumab in inducing repigmentation in vitiligo.
Henry Lee +13 more
wiley +1 more source
Efficacy and safety of ruxolitinib for graft-versus-host disease prophylaxis in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. [PDF]
Front Med (Lausanne)Xie C, Shi L, Wei Z, Lai Y, Liu R.
europepmc +1 more source
Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis
, 2014 Chul Won Jung +27 more
openalex +2 more sources
Ruxolitinib Alleviates Renal Interstitial Fibrosis in UUO Mice [PDF]
, 2019 Yu Bai +8 more
openalex +1 more source
JEADV Clinical Practice, Volume 4, Issue 5, Page 1207-1209, December 2025.ABSTRACT Alopecia areata (AA) and bullous pemphigoid (BP) are distinct autoimmune diseases, but growing evidence points to overlapping immune pathways. We present a rare case of a 71‐year‐old woman with concurrent AA and BP. She initially presented with 10 months of progressive scalp and body hair loss (Severity of Alopecia Tool [SALT] ~ 80) and nail ...
Anna Brinks +6 more
wiley +1 more source
Fostamatinib (R788), a spleen tyrosine kinase inhibitor, sensitizes pancreatic cancer cells to oncolytic vesicular stomatitis virus. [PDF]
Mol Ther OncolCatacalos-Goad C +6 more
europepmc +1 more source